STANFORD, Calif.--(BUSINESS WIRE)--As Philip Beachy, PhD, moves his lab from Johns Hopkins University to the Stanford University School of Medicine, he brings an additional piece to a puzzle that lies at the heart of the school's cancer research efforts: What is the role of cancer stem cells in the disease’s progression?